title: Crosstalk of sterol-dependent and non-sterol-dependent signaling in human monocytes after in vitro addition of LDL.
abstract: The aim of the present study was to investigate low density lipoprotein (LDL)-induced, non-sterol-dependent signaling and its possible role in cholesterol balance. LDL in 10 microg ml(-1) concentration could induce inositol trisphosphate (IP3) and Ca2+ signal generation through a pertussis toxin (PT) sensitive G protein in human monocytes. The increase in [Ca2+]i was derived from the intracellular pools. LDL also induced activation and translocation of protein kinase C (PKC) into the cell membrane, by processes, which were significantly inhibited in the first 20 min by preincubation with PT and PKC-inhibitor H-7. The PKC-activating phorbol-12-myristate-13-acetate (PMA), differently from LDL, enhanced the LDL-receptor (LDL-R)-mediated binding and degradation of [125I]LDL, but inhibited endogenous cholesterol synthesis, and both effects were inhibited by H-7. The LDL-induced inhibition of binding and degradation of [125I]LDL was not affected by H-7, whereas decreased cholesterol synthesis was counteracted by H-7. These results suggest the existence of a non-sterol-dependent signal pathway of LDL-Rs, by which endogenous cholesterol synthesis, that is, the [14C]acetate incorporation, is regulated through PKC activation.
authors.affiliation: First Department of Medicine, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary. seres@internal.med.unideb.hu
authors.forename: Ildikó
authors.initials: I
authors.lastname: Seres
authors.forename: Gabriella
authors.initials: G
authors.lastname: Fóris
authors.forename: Eva
authors.initials: E
authors.lastname: Kovács
authors.forename: Dénes
authors.initials: D
authors.lastname: Páll
authors.forename: Zsuzsa
authors.initials: Z
authors.lastname: Varga
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Balogh
authors.forename: György
authors.initials: G
authors.lastname: Paragh
mesh_terms: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000494:pharmacology; D020013:Calcium Signaling / Q000187:drug effects*; D002478:Cells, Cultured; D006801:Humans; D015544:Inositol 1,4,5-Trisphosphate / Q000378:metabolism; D008297:Male; D009000:Monocytes / Q000187:drug effects* / Q000378:metabolism*; D037342:Pertussis Toxin / Q000494:pharmacology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000378:metabolism; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011973:Receptors, LDL / Q000378:metabolism; D013261:Sterols / Q000378:metabolism* / Q000494:pharmacology*
chemical_list: D047428:Protein Kinase Inhibitors; D011973:Receptors, LDL; D013261:Sterols; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D015544:Inositol 1,4,5-Trisphosphate; D037342:Pertussis Toxin; D011493:Protein Kinase C